危重急性肾损伤患者死亡与主要不良肾脏事件的预测
死亡预测模型(15项特征)AUC优于SOFA评分,MAKE预测模型(14项特征)AUC优于KDIGO AKI分期,两模型在开发队列和验证队列均表现更优(P<0.001)。
要点
- 15项特征模型预测院内死亡AUC在开发队列为0.79,验证队列为0.74,均优于SOFA评分。
- 14项特征模型预测MAKE的AUC在开发队列为0.78,验证队列为0.73,均优于KDIGO分期。
- 模型仅适用于ICU入住3天内发生AKI的危重成人患者,需进一步验证以支持其应用。
核心结论
- 所报告的临床模型在预测危重AKI患者死亡和肾脏恢复方面优于ICU常用的标准评分工具。
- 需要额外验证以支持这些模型的效用和实施。
研究设计与样本
- 多中心队列研究,纳入2009年3月至2017年2月期间入住不同类型ICU的9587例成人患者,这些患者在ICU入住前3天内发生AKI。
- 预测因子为ICU入住前3天内收集的71项多模态临床特征。
- 采用四种机器学习算法(逻辑回归、随机森林、支持向量机、极端梯度提升)和SHAP框架进行特征选择和解释,通过10折交叉验证和外部验证评估模型性能。
主要发现
- 包含15项特征的模型预测院内死亡:开发队列AUC为0.79(95%CI 0.79-0.80),验证队列AUC为0.74(95%CI 0.73-0.74),均优于SOFA评分(开发队列0.71,95%CI 0.71-0.71;验证队列0.71,95%CI 0.71-0.71),P均<0.001。
- 包含14项特征的模型预测MAKE:开发队列AUC为0.78(95%CI 0.78-0.78),验证队列AUC为0.73(95%CI 0.72-0.74),均优于KDIGO AKI分期(开发队列0.66,95%CI 0.66-0.66;验证队列0.67,95%CI 0.67-0.67),P均<0.001。
- MAKE定义为院内死亡或出院后120天内死亡、住院最后48小时内接受肾脏替代治疗、120天内开始维持性肾脏替代治疗、或从基线至出院后120天估算肾小球滤过率下降≥50%的复合终点。
临床怎么用
- 作者指出,所提出的临床模型在结局预测方面表现良好,若进一步验证,或可实现对及时干预以促进肾脏恢复的风险分层。
- 原文未据此给出临床推荐。
局限性
- 模型仅适用于ICU入住前3天内发生AKI的危重成人患者。
- 需要额外验证以支持这些模型的效用和实施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Risk prediction tools for assisting acute kidney injury (AKI) management have focused on AKI onset but have infrequently addressed kidney recovery. We developed clinical models for risk stratification of mortality and major adverse kidney events (MAKE) in critically ill patients with incident AKI. STUDY DESIGN: Multicenter cohort study. SETTING & PARTICIPANTS: 9,587 adult patients admitted to heterogeneous intensive care units (ICUs; March 2009 to February 2017) who experienced AKI within the first 3 days of their ICU stays. PREDICTORS: Multimodal clinical data consisting of 71 features collected in the first 3 days of ICU stay. OUTCOMES: (1) Hospital mortality and (2) MAKE, defined as the composite of death during hospitalization or within 120 days of discharge, receipt of kidney replacement therapy in the last 48 hours of hospital stay, initiation of maintenance kidney replacement therapy within 120 days, or a ≥50% decrease in estimated glomerular filtration rate from baseline to 120 days from hospital discharge. ANALYTICAL APPROACH: Four machine-learning algorithms (logistic regression, random forest, support vector machine, and extreme gradient boosting) and the SHAP (Shapley Additive Explanations) framework were used for feature selection and interpretation. Model performance was evaluated by 10-fold cross-validation and external validation. RESULTS: One developed model including 15 features outperformed the SOFA (Sequential Organ Failure Assessment) score for the prediction of hospital mortality, with areas under the curve of 0.79 (95% CI, 0.79-0.80) and 0.71 (95% CI, 0.71-0.71) in the development cohort and 0.74 (95% CI, 0.73-0.74) and 0.71 (95% CI, 0.71-0.71) in the validation cohort (P < 0.001 for both). A second developed model including 14 features outperformed KDIGO (Kidney Disease: Improving Global Outcomes) AKI severity staging for the prediction of MAKE: 0.78 (95% CI, 0.78-0.78) versus 0.66 (95% CI, 0.66-0.66) in the development cohort and 0.73 (95% CI, 0.72-0.74) versus 0.67 (95% CI, 0.67-0.67) in the validation cohort (P < 0.001 for both). LIMITATIONS: The models are applicable only to critically ill adult patients with incident AKI within the first 3 days of an ICU stay. CONCLUSIONS: The reported clinical models exhibited better performance for mortality and kidney recovery prediction than standard scoring tools commonly used in critically ill patients with AKI in the ICU. Additional validation is needed to support the utility and implementation of these models. PLAIN-LANGUAGE SUMMARY: Acute kidney injury (AKI) occurs commonly in critically ill patients admitted to the intensive care unit (ICU) and is associated with high morbidity and mortality rates. Prediction of mortality and recovery after an episode of AKI may assist bedside decision making. In this report, we describe the development and validation of a clinical model using data from the first 3 days of an ICU stay to predict hospital mortality and major adverse kidney events occurring as long as 120 days after hospital discharge among critically ill adult patients who experienced AKI within the first 3 days of an ICU stay. The proposed clinical models exhibited good performance for outcome prediction and, if further validated, could enable risk stratification for timely interventions that promote kidney recovery.
引用
- Neyra JA, Ortiz-Soriano V, Liu LJ, et al. Prediction of Mortality and Major Adverse Kidney Events in Critically Ill Patients With Acute Kidney Injury. Am J Kidney Dis. 2022. PMID: 35868537. doi:10.1053/j.ajkd.2022.06.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。